Specializing in capsule endoscopy systems, this medical device company develops diagnostic imaging tools for gastrointestinal procedures. Its flagship product, the CapsoCam, offers 360-degree imaging for small bowel examinations, positioning it as a niche player in minimally invasive diagnostics. Investors monitor its growth potential in expanding global markets for gastroenterology technologies.
No congressional trades have been disclosed for CapsoVision, Inc. (CV) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.